Previously, the primary procedure for prostate cancer diagnosis was transrectal ultrasound (TRUS)-guided systematic biopsy based on prostate-specific antigen (PSA) levels and digital rectal examination (DRE) findings. The gene discussed is KLK3; the disease is Familial prostate cancer.